Predictors of Mortality by an Artificial Intelligence Enhanced Electrocardiogram Model for Cardiac Amyloidosis
Jennifer M. Amadio(Mayo Clinic), Angela Dispenzieri(Mayo Clinic), Dennis H. Murphree(Mayo Clinic in Arizona), Paul A. Friedman(Mayo Clinic), Suraj Kapa(Mayo Clinic in Arizona), Francisco Lopez‐Jimenez(Mayo Clinic), Zachi I. Attia(Mayo Clinic), Grace Lin(Mayo Clinic), Surendra Dasari(Mayo Clinic in Arizona), Martha Grogan(Mayo Clinic), Eli Muchtar(Mayo Clinic), Omar F. AbouEzzeddine(Mayo Clinic), Morie A. Gertz(Mayo Clinic), Daniel D. Borgeson(Mayo Clinic)
Cited by 10
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram
|Nature Medicine|2018|1.3k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
|Antimicrobial Agents and Chemotherapy|2010|727